Previous Article | Next Article 
Eukaryotic Cell, October 2003, p. 1003-1008, Vol. 2, No. 5
1535-9778/03/$08.00+0 DOI: 10.1128/EC.2.5.1003-1008.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei
Enock Matovu,1,
Mhairi L. Stewart,2 Federico Geiser,1 Reto Brun,3 Pascal Mäser,1 Lynsey J. M. Wallace,2 Richard J. Burchmore,2 John C. K. Enyaru,4 Michael P. Barrett,2 Ronald Kaminsky,5 Thomas Seebeck,1 and Harry P. de Koning2*
Institute of Cell Biology, CH-3012 Bern,1
Swiss Tropical Institute, CH-4002 Basel,3
Novartis Animal Health, CH-1566 St. Aubin, Switzerland,5
Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom,2
Livestock Health Research Institute, Tororo, Uganda4
Received 24 April 2003/
Accepted 17 July 2003
Sleeping sickness, caused by Trypanosoma brucei spp., has become resurgent in sub-Saharan Africa. Moreover, there is an alarming increase in treatment failures with melarsoprol, the principal agent used against late-stage sleeping sickness. In T. brucei, the uptake of melarsoprol as well as diamidines is thought to be mediated by the P2 aminopurine transporter, and loss of P2 function has been implicated in resistance to these agents. The trypanosomal gene TbAT1 has been found to encode a P2-type transporter when expressed in yeast. Here we investigate the role of TbAT1 in drug uptake and drug resistance in T. brucei by genetic knockout of TbAT1. Tbat1-null trypanosomes were deficient in P2-type adenosine transport and lacked adenosine-sensitive transport of pentamidine and melaminophenyl arsenicals. However, the null mutants were only slightly resistant to melaminophenyl arsenicals and pentamidine, while resistance to other diamidines such as diminazene was more pronounced. Nevertheless, the reduction in drug sensitivity might be of clinical significance, since mice infected with tbat1-null trypanosomes could not be cured with 2 mg of melarsoprol/kg of body weight for four consecutive days, whereas mice infected with the parental line were all cured by using this protocol. Two additional pentamidine transporters, HAPT1 and LAPT1, were still present in the null mutant, and evidence is presented that HAPT1 may be responsible for the residual uptake of melaminophenyl arsenicals. High-level arsenical resistance therefore appears to involve the loss of more than one transporter.
* Corresponding author. Mailing address: Institute of Biomedical and Life Sciences, Division of Infection and Immunity, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom. Phone and fax: 44-141-3303753. E-mail:
H.de-Koning{at}bio.gla.ac.uk.
Present address: Livestock Health Research Institute, Tororo, Uganda.
Eukaryotic Cell, October 2003, p. 1003-1008, Vol. 2, No. 5
1535-9778/03/$08.00+0 DOI: 10.1128/EC.2.5.1003-1008.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wenzler, T., Boykin, D. W., Ismail, M. A., Hall, J. E., Tidwell, R. R., Brun, R.
(2009). New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289. Antimicrob. Agents Chemother.
53: 4185-4192
[Abstract]
[Full Text]
-
Rodenko, B., van der Burg, A. M., Wanner, M. J., Kaiser, M., Brun, R., Gould, M., de Koning, H. P., Koomen, G.-J.
(2007). 2,N6-Disubstituted Adenosine Analogs with Antitrypanosomal and Antimalarial Activities. Antimicrob. Agents Chemother.
51: 3796-3802
[Abstract]
[Full Text]
-
Luscher, A., Onal, P., Schweingruber, A.-M., Maser, P.
(2007). Adenosine Kinase of Trypanosoma brucei and Its Role in Susceptibility to Adenosine Antimetabolites. Antimicrob. Agents Chemother.
51: 3895-3901
[Abstract]
[Full Text]
-
Bridges, D. J., Gould, M. K., Nerima, B., Maser, P., Burchmore, R. J. S., de Koning, H. P.
(2007). Loss of the High-Affinity Pentamidine Transporter Is Responsible for High Levels of Cross-Resistance between Arsenical and Diamidine Drugs in African Trypanosomes. Mol. Pharmacol.
71: 1098-1108
[Abstract]
[Full Text]
-
Lanteri, C. A., Stewart, M. L., Brock, J. M., Alibu, V. P., Meshnick, S. R., Tidwell, R. R., Barrett, M. P.
(2006). Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance. Mol. Pharmacol.
70: 1585-1592
[Abstract]
[Full Text]
-
Stewart, M. L., Boussard, C., Brun, R., Gilbert, I. H., Barrett, M. P.
(2005). Interaction of Monobenzamidine-Linked Trypanocides with the Trypanosoma brucei P2 Aminopurine Transporter. Antimicrob. Agents Chemother.
49: 5169-5171
[Abstract]
[Full Text]
-
Geiser, F., Luscher, A., de Koning, H. P., Seebeck, T., Maser, P.
(2005). Molecular Pharmacology of Adenosine Transport in Trypanosoma brucei: P1/P2 Revisited. Mol. Pharmacol.
68: 589-595
[Abstract]
[Full Text]
-
de Koning, H. P., Anderson, L. F., Stewart, M., Burchmore, R. J. S., Wallace, L. J. M., Barrett, M. P.
(2004). The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes. Antimicrob. Agents Chemother.
48: 1515-1519
[Abstract]
[Full Text]
-
Stewart, M. L., Bueno, G. J., Baliani, A., Klenke, B., Brun, R., Brock, J. M., Gilbert, I. H., Barrett, M. P.
(2004). Trypanocidal Activity of Melamine-Based Nitroheterocycles. Antimicrob. Agents Chemother.
48: 1733-1738
[Abstract]
[Full Text]
-
Landfear, S. M., Ullman, B., Carter, N. S., Sanchez, M. A.
(2004). Nucleoside and Nucleobase Transporters in Parasitic Protozoa. Eukaryot Cell
3: 245-254
[Full Text]